⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15039428 | 1.00 | — | — | |
| SCHEMBL15039429 | 0.86 | — | — | |
| SCHEMBL15039521 | 0.86 | — | — | |
| SCHEMBL15039430 | 0.86 | — | — | |
| SCHEMBL15039434 | 0.86 | — | — | |
| SCHEMBL15039346 | 0.82 | — | — | |
| SCHEMBL17955122 | 0.78 | — | — | |
| SCHEMBL17955142 | 0.78 | — | — | |
| SCHEMBL18220849 | 0.78 | — | — | |
| SCHEMBL18220830 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130156845-A1 | LIPID FORMULATED SINGLE STRANDED RNA | ALNYLAM PHARMACEUTICALS, INC. (US) | 2013-06-20 | — | — | US | disclosed |